Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
symbols : INCY crawled date : 2021 - 04 - 23 save search
Hematology/Oncology (Cancer) Approvals & Safety Notifications
Published: 2021-04-23 (Crawled : 18:42) - fda.gov
LLY | News | $732.2 -1.81% -0.84% 1.7M
|
Health Technology
| Email alert
Add to watchlist
RIGL | $1.125 -1.32% -1.33% 6.5M
|
Health Technology
| Email alert
Add to watchlist
ILMN | $122.87 -1.28% -1.4% 720K
|
Health Technology
| Email alert
Add to watchlist
BMY | $48.86 -0.27% 0.98% 14M
|
Health Technology
| Email alert
Add to watchlist
BGNE | $144.12 3.69% 3.48% 150
|
Health Technology
| Email alert
Add to watchlist
CLVS | $0.0812 -3.94%
|
Health Technology
| Email alert
Add to watchlist
KPTI | $1.09 0.91% 1.2M
|
Health Technology
| Email alert
Add to watchlist
ALNY | $143.8 -1.55% -1.58% 400K
|
Health Technology
| Email alert
Add to watchlist
PFE | News 4 | $26.27 -0.19% 0.19% 18M
|
Health Technology
| Email alert
Add to watchlist
ABBV | News | $167.8 -1.03% -0.02% 2.9M
|
Health Technology
| Email alert
Add to watchlist
AGIO | $31.67 -0.44% -0.44% 640K
|
Health Technology
| Email alert
Add to watchlist
VSTM | $9.31 -3.12% -3.44% 79K
|
Health Technology
| Email alert
Add to watchlist
EPZM | $1.47 -1.34% 0.0%
|
Health Technology
| Email alert
Add to watchlist
REGN | News | $906.54 -0.09% -0.08% 280K
|
Health Technology
| Email alert
Add to watchlist
AVEO | $15.0 0.0% 0
|
Health Technology
| Email alert
Add to watchlist
YMAB | $15.29 -0.33% -0.52% 160K
|
Health Technology
| Email alert
Add to watchlist
BPMC | $92.26 -0.03% 0.02% 590K
|
Health Technology
| Email alert
Add to watchlist
EXEL | $23.71 1.8% 1.73% 12
|
Health Technology
| Email alert
Add to watchlist
ADCT | $4.78 -3.82% 2.3% 19
|
Health Technology
| Email alert
Add to watchlist
SNY | News | $46.61 -2.27% -2.21% 1.6M
|
Health Technology
| Email alert
Add to watchlist
AMGN | News | $273.01 -0.19% -0.17% 400
|
Health Technology
| Email alert
Add to watchlist
INCY | $51.74 0.17% 0.14% 1.6M
|
Health Technology
| Email alert
Add to watchlist
cancer approval
Incyte Announces New Findings from Pooled Analyses of the Phase 3 TRuE-AD Program Evaluating Ruxolitinib Cream in Patients with Atopic Dermatitis
Published: 2021-04-23 (Crawled : 18:00) - biospace.com/
INCY | $51.74 0.17% 0.14% 1.6M
|
Health Technology
|
| O: 0.5%
H: 1.3%
C: 1.16%
dermatitis phase 3 atopic dermatitis
Incyte Announces New Findings from a Randomized Phase 2 Study of Ruxolitinib Cream in Patients with Vitiligo
Published: 2021-04-23 (Crawled : 18:00) - biospace.com/
INCY | $51.74 0.17% 0.14% 1.6M
|
Health Technology
|
| O: 0.5%
H: 1.3%
C: 1.16%
phase 2
OLUMIANT® Showed Significant Improvements in the Severity and Extent of Atopic Dermatitis and Other Patient-Reported Outcomes in Phase 3 Study Analyses
Published: 2021-04-23 (Crawled : 17:00) - biospace.com/
LLY | News | $732.2 -1.81% -0.84% 1.7M
|
Health Technology
|
| O: -0.01%
H: 1.12%
C: 0.9%
INCY | $51.74 0.17% 0.14% 1.6M
|
Health Technology
|
| O: 0.5%
H: 1.3%
C: 1.16%
dermatitis phase 3 atopic dermatitis
Gainers vs Losers
| 61% | 39% |
Top 10 Gainers
BOF | $2.08 77.78% 39.06% 110M
|
BHIL | $0.1793 -4.37% 19.24% 340K
|
Agriculture, Forestry, Fishing ...
UMAC | $1.48 -1.33% 14.87% 20K
|
CI | $352.28 -0.11% 13.53% 2
|
Health Services
CIG.C | $2.89 -1.37% 12.8% 2.3K
|
n/a
MTH | $154.69 -2.21% 12.68% 450K
|
Consumer Durables
HCP | News | $31.41 7.75% 11.26% 1.2M
|
BMTX 4 | $1.545 0.98% 10.03% 2.5K
|
Information
TAL | $12.26 0.57% 9.22% 12M
|
Consumer Services
ASXC | $0.243 -2.41% 7.0% 1.1M
|
Manufacturing
Your saved searches
Save your searches and get alerts when important news are released.